Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy
- PMID: 16918477
- PMCID: PMC2629541
- DOI: 10.2174/187152806778256098
Natural and induced regulatory T cells: targets for immunotherapy of autoimmune disease and allergy
Abstract
Recent advances in immunology have greatly increased our understanding of immunological tolerance. In particular, there has been a resurgence of interest in mechanisms of immune regulation. Immune regulation refers to the phenomenon, previously known as immune suppression, by which excessive responses to infectious agents and hypersensitivities to otherwise innocuous antigens such as self antigens and allergens are avoided. We now appreciate that various distinct cell types mediate immune suppression and that some of these may be induced by appropriate administration of antigens, synthetic peptides and drugs of various types. The induction of antigen specific immunotherapy for treatment of autoimmune and allergic diseases remains the 'holy grail' for treatment of these diseases. This goal comes ever closer as understanding of the mechanisms of immune suppression and in particular antigen specific immunotherapy increases. Here we review evidence that immune suppression is mediated by various different subsets of CD4 T cells.
Figures

Similar articles
-
Extra-thymically induced T regulatory cell subsets: the optimal target for antigen-specific immunotherapy.Immunology. 2015 Jun;145(2):171-81. doi: 10.1111/imm.12458. Immunology. 2015. PMID: 25716063 Free PMC article. Review.
-
CD4+CD25+ regulatory T-cell therapy for allergy, autoimmune disease and transplant rejection.Inflamm Allergy Drug Targets. 2006 Dec;5(4):239-42. doi: 10.2174/187152806779010981. Inflamm Allergy Drug Targets. 2006. PMID: 17168794 Review.
-
Therapeutic peptide vaccines for treatment of autoimmune diseases.Immunol Lett. 2009 Feb 21;122(2):134-6. doi: 10.1016/j.imlet.2008.11.013. Epub 2008 Dec 25. Immunol Lett. 2009. PMID: 19100774 Free PMC article. Review.
-
A review of the mechanisms of oral tolerance and immunotherapy.J R Soc Med. 1995 Jan;88(1):14-7. J R Soc Med. 1995. PMID: 7884761 Free PMC article. Review.
-
Novel therapeutic strategies by regulatory T cells in allergy.Chem Immunol Allergy. 2008;94:150-157. doi: 10.1159/000154999. Chem Immunol Allergy. 2008. PMID: 18802345 Review.
Cited by
-
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.Cytotherapy. 2010 Oct;12(6):743-9. doi: 10.3109/14653241003709686. Cytotherapy. 2010. PMID: 20429793 Free PMC article.
-
Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis.Am J Pathol. 2009 Jun;174(6):2202-10. doi: 10.2353/ajpath.2009.081041. Epub 2009 Apr 30. Am J Pathol. 2009. PMID: 19406992 Free PMC article.
References
-
- Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D. Science. 2002;298:1395. - PubMed
-
- Su MA, Anderson MS. Curr. Opin. Immunol. 2004;16:746. - PubMed
-
- Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. J. Immunol. 1995;155:1151. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials